Logo image of KIN2.DE

KINROSS GOLD CORP (KIN2.DE) Stock Fundamental Analysis

FRA:KIN2 - Deutsche Boerse Ag - CA4969024047 - Common Stock - Currency: EUR

12.8  -0.3 (-2.29%)

Fundamental Rating

6

Taking everything into account, KIN2 scores 6 out of 10 in our fundamental rating. KIN2 was compared to 37 industry peers in the Metals & Mining industry. KIN2 gets an excellent profitability rating and is at the same time showing great financial health properties. KIN2 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

KIN2 had positive earnings in the past year.
In the past year KIN2 had a positive cash flow from operations.
Of the past 5 years KIN2 4 years were profitable.
In the past 5 years KIN2 always reported a positive cash flow from operatings.
KIN2.DE Yearly Net Income VS EBIT VS OCF VS FCFKIN2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

KIN2 has a Return On Assets of 8.73%. This is amongst the best in the industry. KIN2 outperforms 86.49% of its industry peers.
KIN2 has a better Return On Equity (13.83%) than 81.08% of its industry peers.
With an excellent Return On Invested Capital value of 9.40%, KIN2 belongs to the best of the industry, outperforming 81.08% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for KIN2 is in line with the industry average of 6.44%.
The last Return On Invested Capital (9.40%) for KIN2 is above the 3 year average (6.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.73%
ROE 13.83%
ROIC 9.4%
ROA(3y)2.29%
ROA(5y)4.25%
ROE(3y)3.43%
ROE(5y)6.8%
ROIC(3y)6.23%
ROIC(5y)6.54%
KIN2.DE Yearly ROA, ROE, ROICKIN2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

The Profit Margin of KIN2 (18.43%) is better than 86.49% of its industry peers.
KIN2's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 28.48%, KIN2 belongs to the top of the industry, outperforming 91.89% of the companies in the same industry.
In the last couple of years the Operating Margin of KIN2 has grown nicely.
With a decent Gross Margin value of 35.04%, KIN2 is doing good in the industry, outperforming 64.86% of the companies in the same industry.
In the last couple of years the Gross Margin of KIN2 has grown nicely.
Industry RankSector Rank
OM 28.48%
PM (TTM) 18.43%
GM 35.04%
OM growth 3Y9.12%
OM growth 5Y8.75%
PM growth 3Y45.92%
PM growth 5Y-2.15%
GM growth 3Y3.98%
GM growth 5Y4.42%
KIN2.DE Yearly Profit, Operating, Gross MarginsKIN2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KIN2 is creating some value.
Compared to 1 year ago, KIN2 has about the same amount of shares outstanding.
Compared to 5 years ago, KIN2 has less shares outstanding
Compared to 1 year ago, KIN2 has an improved debt to assets ratio.
KIN2.DE Yearly Shares OutstandingKIN2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
KIN2.DE Yearly Total Debt VS Total AssetsKIN2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

KIN2 has an Altman-Z score of 2.66. This is not the best score and indicates that KIN2 is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.66, KIN2 is in the better half of the industry, outperforming 78.38% of the companies in the same industry.
KIN2 has a debt to FCF ratio of 1.05. This is a very positive value and a sign of high solvency as it would only need 1.05 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.05, KIN2 belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
KIN2 has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.18, KIN2 is doing good in the industry, outperforming 64.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.05
Altman-Z 2.66
ROIC/WACC1.09
WACC8.61%
KIN2.DE Yearly LT Debt VS Equity VS FCFKIN2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.01 indicates that KIN2 has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.01, KIN2 is in the better half of the industry, outperforming 75.68% of the companies in the same industry.
KIN2 has a Quick Ratio of 2.01. This is a bad value and indicates that KIN2 is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.83, KIN2 is in line with its industry, outperforming 43.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 0.83
KIN2.DE Yearly Current Assets VS Current LiabilitesKIN2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.23% over the past year.
The Earnings Per Share has been growing by 14.87% on average over the past years. This is quite good.
The Revenue has grown by 26.71% in the past year. This is a very strong growth!
KIN2 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.04% yearly.
EPS 1Y (TTM)87.23%
EPS 3Y17.42%
EPS 5Y14.87%
EPS Q2Q%200%
Revenue 1Y (TTM)26.71%
Revenue growth 3Y11.35%
Revenue growth 5Y8.04%
Sales Q2Q%38.47%

3.2 Future

KIN2 is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.48% yearly.
KIN2 is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.78% yearly.
EPS Next Y40.71%
EPS Next 2Y20.9%
EPS Next 3Y14.28%
EPS Next 5Y-4.48%
Revenue Next Year16.44%
Revenue Next 2Y9.09%
Revenue Next 3Y5.54%
Revenue Next 5Y-4.78%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
KIN2.DE Yearly Revenue VS EstimatesKIN2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
KIN2.DE Yearly EPS VS EstimatesKIN2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6 0.8 1

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.41 indicates a correct valuation of KIN2.
Compared to the rest of the industry, the Price/Earnings ratio of KIN2 is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.25. KIN2 is valued slightly cheaper when compared to this.
KIN2 is valuated correctly with a Price/Forward Earnings ratio of 14.53.
KIN2's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of KIN2 to the average of the S&P500 Index (22.15), we can say KIN2 is valued slightly cheaper.
Industry RankSector Rank
PE 16.41
Fwd PE 14.53
KIN2.DE Price Earnings VS Forward Price EarningsKIN2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

KIN2's Enterprise Value to EBITDA ratio is in line with the industry average.
KIN2's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KIN2 is cheaper than 86.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.92
EV/EBITDA 7.16
KIN2.DE Per share dataKIN2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of KIN2 may justify a higher PE ratio.
A more expensive valuation may be justified as KIN2's earnings are expected to grow with 14.28% in the coming years.
PEG (NY)0.4
PEG (5Y)1.1
EPS Next 2Y20.9%
EPS Next 3Y14.28%

2

5. Dividend

5.1 Amount

KIN2 has a yearly dividend return of 0.81%, which is pretty low.
KIN2's Dividend Yield is comparable with the industry average which is at 3.11.
Compared to an average S&P500 Dividend Yield of 2.40, KIN2's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.81%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
KIN2.DE Yearly Dividends per shareKIN2.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 0.05 0.1 0.15

5.3 Sustainability

KIN2 pays out 15.55% of its income as dividend. This is a sustainable payout ratio.
DP15.55%
EPS Next 2Y20.9%
EPS Next 3Y14.28%
KIN2.DE Yearly Income VS Free CF VS DividendKIN2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
KIN2.DE Dividend Payout.KIN2.DE Dividend Payout, showing the Payout Ratio.KIN2.DE Dividend Payout.PayoutRetained Earnings

KINROSS GOLD CORP

FRA:KIN2 (5/30/2025, 7:00:00 PM)

12.8

-0.3 (-2.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)07-30 2025-07-30
Inst Owners68.64%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap15.70B
Analysts80
Price Target15.5 (21.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.81%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP15.55%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.54%
Min EPS beat(2)-18.81%
Max EPS beat(2)25.89%
EPS beat(4)3
Avg EPS beat(4)16.49%
Min EPS beat(4)-18.81%
Max EPS beat(4)57.06%
EPS beat(8)7
Avg EPS beat(8)29.26%
EPS beat(12)8
Avg EPS beat(12)13.27%
EPS beat(16)10
Avg EPS beat(16)12.49%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)17.44%
PT rev (3m)19.54%
EPS NQ rev (1m)3.36%
EPS NQ rev (3m)5.41%
EPS NY rev (1m)0%
EPS NY rev (3m)13.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.86%
Revenue NY rev (3m)8.04%
Valuation
Industry RankSector Rank
PE 16.41
Fwd PE 14.53
P/S 3.44
P/FCF 12.92
P/OCF 7.24
P/B 2.58
P/tB 2.58
EV/EBITDA 7.16
EPS(TTM)0.78
EY6.09%
EPS(NY)0.88
Fwd EY6.88%
FCF(TTM)0.99
FCFY7.74%
OCF(TTM)1.77
OCFY13.81%
SpS3.72
BVpS4.96
TBVpS4.96
PEG (NY)0.4
PEG (5Y)1.1
Profitability
Industry RankSector Rank
ROA 8.73%
ROE 13.83%
ROCE 14.95%
ROIC 9.4%
ROICexc 10.02%
ROICexgc 10.02%
OM 28.48%
PM (TTM) 18.43%
GM 35.04%
FCFM 26.63%
ROA(3y)2.29%
ROA(5y)4.25%
ROE(3y)3.43%
ROE(5y)6.8%
ROIC(3y)6.23%
ROIC(5y)6.54%
ROICexc(3y)6.62%
ROICexc(5y)7.08%
ROICexgc(3y)6.62%
ROICexgc(5y)7.14%
ROCE(3y)9.92%
ROCE(5y)10.4%
ROICexcg growth 3Y20.62%
ROICexcg growth 5Y13.48%
ROICexc growth 3Y21.33%
ROICexc growth 5Y13.94%
OM growth 3Y9.12%
OM growth 5Y8.75%
PM growth 3Y45.92%
PM growth 5Y-2.15%
GM growth 3Y3.98%
GM growth 5Y4.42%
F-Score7
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.05
Debt/EBITDA 0.47
Cap/Depr 93.73%
Cap/Sales 20.89%
Interest Coverage 11.44
Cash Conversion 93.6%
Profit Quality 144.49%
Current Ratio 2.01
Quick Ratio 0.83
Altman-Z 2.66
F-Score7
WACC8.61%
ROIC/WACC1.09
Cap/Depr(3y)100.83%
Cap/Depr(5y)104.58%
Cap/Sales(3y)22.97%
Cap/Sales(5y)23.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.23%
EPS 3Y17.42%
EPS 5Y14.87%
EPS Q2Q%200%
EPS Next Y40.71%
EPS Next 2Y20.9%
EPS Next 3Y14.28%
EPS Next 5Y-4.48%
Revenue 1Y (TTM)26.71%
Revenue growth 3Y11.35%
Revenue growth 5Y8.04%
Sales Q2Q%38.47%
Revenue Next Year16.44%
Revenue Next 2Y9.09%
Revenue Next 3Y5.54%
Revenue Next 5Y-4.78%
EBIT growth 1Y74.49%
EBIT growth 3Y21.5%
EBIT growth 5Y17.5%
EBIT Next Year131.51%
EBIT Next 3Y30.48%
EBIT Next 5Y4.98%
FCF growth 1Y170.39%
FCF growth 3Y91.05%
FCF growth 5Y62.85%
OCF growth 1Y52.4%
OCF growth 3Y29.17%
OCF growth 5Y14.84%